Advertisement
Advertisement
MLAB
Mesa Laboratories Inc
95.48
USDSponsored
+2.66
+2.86%
Apr 10, 14:34 UTC -4
Open
MLAB Earnings Reports
Positive Surprise Ratio
MLAB beat 20 of 40 last estimates.
50%
Next Report
Date of Next Report
May 26, 2026
Estimate for Q4 26 (Revenue/ EPS)
$66.47M
/$0.34
Implied change from Q3 26 (Revenue/ EPS)
+2.07%
/-47.69%
Implied change from Q4 25 (Revenue/ EPS)
+6.98%
/-125.95%
Mesa Laboratories Inc earnings per share and revenue
On Feb 03, 2026, MLAB reported earnings of 0.65 USD per share (EPS) for Q3 26, beating the estimate of 0.28 USD, resulting in a 130.33% surprise. Revenue reached 65.13 million, compared to an expected 64.63 million, with a 0.77% difference. The market reacted with a +8.73% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 5 analysts forecast an EPS of 0.34 USD, with revenue projected to reach 66.47 million USD, implying an decrease of -47.69% EPS, and increase of 2.07% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
FAQ
What were Mesa Laboratories Inc's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Mesa Laboratories Inc reported EPS of $0.65, beating estimates by 130.33%, and revenue of $65.13M, 0.77% above expectations.
How did the market react to Mesa Laboratories Inc's Q3 2026 earnings?
The stock price moved up 8.73%, changed from $80.50 before the earnings release to $87.53 the day after.
When is Mesa Laboratories Inc expected to report next?
The next earning report is scheduled for May 26, 2026.
What are the forecasts for Mesa Laboratories Inc's next earnings report?
Based on 5
analysts, Mesa Laboratories Inc is expected to report EPS of $0.34 and revenue of $66.47M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement